                         SEQUENCE LISTING

<110>  Bristol-Myers Squibb Company
 
<120>  PAR4 Agonist Peptides

<130>  12135-WO-PCT

<150>  61/638,577
<151>  2012-04-26

<150>  61/781,538
<151>  2013-03-14

<160>  35    

<170>  PatentIn version 3.5

<210>  1
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide

<400>  1

Ala Tyr Pro Gly Lys Phe 
1               5       


<210>  2
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide

<400>  2

Ala Tyr Pro Gly Trp Leu Val Lys Asn Gly 
1               5                   10  


<210>  3
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<400>  3

Ala Xaa Pro Gly Trp Leu Val Lys Asn Gly 
1               5                   10  


<210>  4
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<400>  4

Ala Xaa Pro Gly Trp Leu Val Lys Asn 
1               5                   


<210>  5
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<400>  5

Ala Xaa Pro Gly Trp Leu Val Lys 
1               5               


<210>  6
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<400>  6

Ala Xaa Pro Gly Trp Leu Val 
1               5           


<210>  7
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<400>  7

Ala Xaa Pro Gly Trp Leu 
1               5       


<210>  8
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<400>  8

Ala Xaa Pro Gly Trp 
1               5   


<210>  9
<211>  4
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<400>  9

Ala Xaa Pro Gly 
1               


<210>  10
<211>  4
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide

<400>  10

Ala Tyr Pro Gly 
1               


<210>  11
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide

<400>  11

Ala Tyr Pro Gly Gln Val Cys Ala Asn Asp 
1               5                   10  


<210>  12
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = Trp(5-OH)

<400>  12

Ala Xaa Pro Gly Xaa Leu Val 
1               5           


<210>  13
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = (D,L)-Trp(5-Br)

<400>  13

Ala Xaa Pro Gly Xaa Leu Val 
1               5           


<210>  14
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Zaa = Phe(4-F)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Zaa = D-Trp

<400>  14

Ala Xaa Pro Gly Xaa Leu Val 
1               5           


<210>  15
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = Bzt

<400>  15

Ala Xaa Pro Gly Xaa Leu Val 
1               5           


<210>  16
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = Tpi

<400>  16

Ala Xaa Pro Gly Xaa Leu Val 
1               5           


<210>  17
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<400>  17

Ala Xaa Pro Gly His Leu Val 
1               5           


<210>  18
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Phe(4-F)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Tza

<400>  18

Ala Xaa Pro Gly Xaa Leu Val 
1               5           


<210>  19
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = 3-Thi

<400>  19

Ala Xaa Pro Gly Xaa Leu Val 
1               5           


<210>  20
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = 3-Fur

<400>  20

Ala Xaa Pro Gly Xaa Leu Val 
1               5           


<210>  21
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = His(Bzl)

<400>  21

Ala Xaa Pro Gly Xaa Leu Val 
1               5           


<210>  22
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<400>  22

Ala Xaa Pro Gly Phe Leu Val 
1               5           


<210>  23
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<400>  23

Ala Xaa Pro Gly Tyr Leu Val 
1               5           


<210>  24
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = Phe(penta-F)

<400>  24

Ala Xaa Pro Gly Xaa Leu Val 
1               5           


<210>  25
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = 2-Pya

<400>  25

Ala Xaa Pro Gly Xaa Leu Val 
1               5           


<210>  26
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = 3-Pya

<400>  26

Ala Xaa Pro Gly Xaa Leu Val 
1               5           


<210>  27
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = 4-Pya

<400>  27

Ala Xaa Pro Gly Xaa Leu Val 
1               5           


<210>  28
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = Dpa

<400>  28

Ala Xaa Pro Gly Xaa Leu Val 
1               5           


<210>  29
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = 3-Pya(4-Tolyl)

<400>  29

Ala Xaa Pro Gly Xaa Leu Val 
1               5           


<210>  30
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = Bip(2-Methyl)

<400>  30

Ala Xaa Pro Gly Xaa Leu Val 
1               5           


<210>  31
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = 1-Naphthyl-Ala

<400>  31

Ala Xaa Pro Gly Xaa Leu Val 
1               5           


<210>  32
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = 2-Naphthyl-Ala

<400>  32

Ala Xaa Pro Gly Xaa Leu Val 
1               5           


<210>  33
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = Tyr(Bzl)

<400>  33

Ala Xaa Pro Gly Xaa Leu Val 
1               5           


<210>  34
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Phe(4-F)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = Styryl-Ala

<400>  34

Ala Xaa Pro Gly Xaa Leu Val 
1               5           


<210>  35
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide

<400>  35

Ser Phe Phe Leu Arg Arg 
1               5       


